Acute Coronary Syndrome After Insecticide Spraying: A Suspected Association with Organophosphate Exposure
Case Report
DOI:
https://doi.org/10.55175/cdk.v52i9.1374Keywords:
Case report, insecticides spraying, organophosphate, STEMIAbstract
Introduction: Organophosphate is one of the most commonly used insecticides to control vector-borne illnesses. Both organophosphate and biodiesel (commonly used as solvents for outdoor space spraying methods) intoxications have cardiovascular manifestations. Case: A 58-year-old male with a sudden onset of shortness of breath after spraying insecticides 1 hour before admission. On examination, there were no SLUDGEM (salivation, lacrimation, urination, defecation, gastrointestinal distress, emesis, miosis) fndings. Bibasilar rales were present on auscultation, and a 12-lead ECG showed ST elevation in leads V1-V6. There was no preceding chest pain. The patient received oxygen, antiplatelet loading, and insulin therapy for hyperglycemia and was prepared for primary PCI. Diagnostic coronary angiography revealed a mid-LAD total occlusion, and a drug-eluting stent was implanted with fnal TIMI 3 fow. Discussion: Dyspnea has various causes, including organophosphate (OP) poisoning, which may result in cholinergic syndrome, respiratory dysfunction, and life-threatening cardiovascular complications. Early recognition through rapid diagnostic evaluation and timely interventions such as atropine, oximes, and reperfusion therapy in STEMI are essential to improve survival and outcomes. Conclusion: Early recognition and prompt revascularization are critical in STEMI to reduce infarct size and improve outcomes. Organophosphate exposure may be associated with cardiovascular efects, and clinicians should consider acute coronary occlusion in patients with respiratory complaints after insecticide exposure, even in the absence of classical cholinergic signs.
Downloads
References
El-Sheikh A, Hashem A, Elgohary M, Elfadl AA, Lashin H. Evaluation of the potential cardiotoxic effects in acute organophosphate toxicity as a prognostic factor. Tanta Med J. 2017;45(3):115-21. doi: 10.4103/tmj.tmj_5_17.
Kiss Z, Fazekas T. Arrhythmias in organophosphate poisonings. Acta Cardiol. 1979;34(5):323–30. PMID: 317206.
Kidiyoor Y, Nayak VC, Devi V, Bakkannavar SM, Kumar GP, Menezes RG. A rare case of myocardial infarction due to parathion poisoning. J Forensic Leg Med. 2009;16(8):472–4. doi: 10.1016/j.jflm.2009.05.003.
Walls RM, Hockberger RS, Gausche-Hill M, Erickson TB, Wilcox SR. Rosen’s emergency medicine: concepts and clinical practice [Internet]. Elsevier; 2022. Available from: https://books.google.co.id/books?id=U6iXzgEACAAJ.
Santus P, Radovanovic D, Saad M, Zilianti C, Coppola S, Chiumello DA, et al. Acute dyspnea in the emergency department: a clinical review. Intern Emerg Med. 2023 Aug;18(5):1491-1507. doi: 10.1007/s11739-023-03322-8.
Baydin A, Erenler AK, Yardan T, Kati C, Duran L, Dilek A. Acute organophosphate poisoning in adults: a 10-year analysis. Health Med J. 2014;8(2):151–60.
Peter JV, Sudarsan TI, Moran JL. Clinical features of organophosphate poisoning: a review of different classification systems and approaches. Indian J Crit Care Med. 2014;18(11):735. doi: 10.4103/0972-5229.144017.
Hodgson E, Rose RL. The importance of cytochrome P450 2B6 in the human metabolism of environmental chemicals. Pharmacol Ther. 2007;113(2):420–8. doi: 10.1016/j.pharmthera.2006.10.002.
Iyer R, Iken B, Leon A. Developments in alternative treatments for organophosphate poisoning. Toxicol Lett. 2015;233(2):200–6. doi: 10.1016/j.toxlet.2015.01.007.
King AM, Aaron CK. Organophosphate and carbamate poisoning. Emergency Med Clin. 2015;33(1):133–51. doi: 10.1016/j.emc.2014.09.010.
Akdur O, Durukan P, Ozkan S, Avsarogullari L, Vardar A, Kavalci C, et al. Poisoning severity score, Glasgow coma scale, corrected QT interval in acute organophosphate poisoning. Hum Exp Toxicol. 2010;29(5):419–25. doi: 10.1177/0960327110364640.
Konur O. Biodiesel and petrodiesel fuels: science, technology, health, and the environment. Biodiesel Fuels. Florida: CRC Press; 2021 .p. 1195–200.
Vogel B, Claessen BE, Arnold S V, Chan D, Cohen DJ, Giannitsis E, et al. ST-segment elevation myocardial infarction. Nat Rev Dis Primers. 2019;5(1):39. doi: 10.1038/s41572-019-0090-3
Engelen SE, Robinson AJB, Zurke YX, Monaco C. Therapeutic strategies targeting inflammation and immunity in atherosclerosis: how to proceed ? Nat Rev Cardiol. 2022;19(8):522–42. doi: 10.1038/s41569-021-00668-4.
Partow-Navid R, Prasitlumkum N, Mukherjee A, Varadarajan P, Pai RG. Management of ST elevation myocardial infarction (STEMI) in different settings. Internat J Angiol. 2021;30(01):67–75. doi: 10.1055/s-0041-1723944.
Nakashima T, Tahara Y. Achieving the earliest possible reperfusion in patients with acute coronary syndrome: a current overview. J Intensive Care 2018;6(1):20. doi: 10.1186/s40560-018-0285-9.
Scholz KH, Meyer T, Lengenfelder B, Vahlhaus C, Tongers J, Schnupp S, et al. Patient delay and benefit of timely reperfusion in ST-segment elevation myocardial infarction. Open Heart [Internet]. 2021;8(1):e001650. Available from: http://openheart.bmj.com/content/8/1/e001650.abstract.
Seetharam SP, Shankar V, Udupa K, Anjanappa R, Reddy N. Quality of life assessment in the first episode of acute coronary syndrome. J Clin Transl Res. 2023;9(4):265. PMID: 37593241.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Hari Adityo Nugroho, Istan Irmansyah Irsan, Mardani Cahyono
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
